Analysis

Following a record-breaking 2025 that saw revenues reach the tens of millions, Empress Royalty is now focused on its next...

Bayer's recently published annual report for 2025 delivers an unambiguous message: the legal risks associated with glyphosate continue to overshadow...

Despite launching a significant share repurchase initiative, Xiaomi Corporation's stock continues to face substantial downward pressure. Investor confidence remains elusive...

During a recent investor conference, Realty Income's CEO Sumit Roy outlined the real estate investment trust's (REIT) strategic priorities for...

A coordinated military strike by the United States and Israel against Iran over the weekend has propelled Chevron's stock toward...

Biopharmaceutical firm Ocugen has achieved a significant clinical development goal just two days before its annual financial report. Company leadership...

Salesforce has solidified its previously reported fiscal 2026 performance with the formal submission of its annual 10-K report. The filing...

NRx Pharmaceuticals is bolstering its executive team with a strategic hire aimed at accelerating the development of novel neuroplastic treatments....

After years of extreme price swings and tight supplies, the global coffee market is showing tentative signs of easing as...

While Orchid Island Capital itself has been quiet on the corporate news front recently, investors are far from idle. Market...